KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Free Cash Flow: 2014-2024

Historic Free Cash Flow for BeOne Medicines (ONC) over the last 11 years, with Dec 2024 value amounting to -$633.3 million.

  • BeOne Medicines' Free Cash Flow rose 547.86% to $354.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $544.6 million, marking a year-over-year increase of 154.76%. This contributed to the annual value of -$633.3 million for FY2024, which is 63.17% up from last year.
  • Latest data reveals that BeOne Medicines reported Free Cash Flow of -$633.3 million as of FY2024, which was up 63.17% from -$1.7 billion recorded in FY2023.
  • BeOne Medicines' 5-year Free Cash Flow high stood at -$633.3 million for FY2024, and its period low was -$1.8 billion during FY2022.
  • Over the past 3 years, BeOne Medicines' median Free Cash Flow value was -$1.7 billion (recorded in 2023), while the average stood at -$1.4 billion.
  • As far as peak fluctuations go, BeOne Medicines' Free Cash Flow plummeted by 96.61% in 2022, and later skyrocketed by 63.17% in 2024.
  • BeOne Medicines' Free Cash Flow (Yearly) stood at -$1.4 billion in 2020, then skyrocketed by 33.85% to -$926.7 million in 2021, then plummeted by 96.61% to -$1.8 billion in 2022, then rose by 5.64% to -$1.7 billion in 2023, then soared by 63.17% to -$633.3 million in 2024.